▶ 調査レポート

メサラミンのグローバル販売市場 2020年

• 英文タイトル:Global Mesalamine Sales Market Report 2020
• レポートコード:MRC2102QY8825
• 出版社/出版日: / 2021年1月
• レポート形態:英文、PDF、147ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥528,000 (USD4,000)▷ お問い合わせ
  Multi User¥792,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,056,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界のメサラミン市場について種類別(純度≥97%、純度≥98%、純度≥99%)、用途別(メサラジン錠、メサラジンカプセル、その他)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・メサラミン市場の概要
・世界の主要地域別メサラミン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のメサラミン市場規模2015-2026:種類別(純度≥97%、純度≥98%、純度≥99%)
・世界のメサラミン市場規模2015-2026:用途別(メサラジン錠、メサラジンカプセル、その他)
・メサラミンの米国市場規模2015-2020
・メサラミンのヨーロッパ市場規模2015-2020
・メサラミンの中国市場規模2015-2020
・メサラミンの日本市場規模2015-2020
・メサラミンの東南アジア市場規模2015-2020
・メサラミンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・メサラミンの製造コスト分析
・販売チャネル、流通業者、顧客
・メサラミンの市場動向・機会・課題
・調査の結論

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn’s disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The industry’s leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively.
In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019.

Market Analysis and Insights: Global Mesalamine Market
The global Mesalamine market size is projected to reach US$ 183.2 million by 2026, from US$ 151.5 million in 2020, at a CAGR of 3.2% during 2021-2026.

Global Mesalamine Scope and Market Size
The global Mesalamine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mesalamine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Mesalamine market is segmented into
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%
According to the type, Mesalamine whose Purity ≥ 99% accounted for the largest global revenue share with 43.73% in 2019.

Segment by Application, the Mesalamine market is segmented into
Mesalazine Tablets
Mesalazine Capsules
Others
Mesalazine Tablets took the largest market share in terms of volume, with 42.15% in 2019.

The Mesalamine market is analysed and market size information is provided by regions (countries). Segment by Application, the Mesalamine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Mesalamine Market Share Analysis
Mesalamine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Mesalamine business, the date to enter into the Mesalamine market, Mesalamine product introduction, recent developments, etc.

The major vendors covered:
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
Hangzhou Brother
PharmaZell
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical

レポート目次

1 Mesalamine Market Overview
1.1 Mesalamine Product Scope
1.2 Mesalamine Segment by Type
1.2.1 Global Mesalamine Sales by Type (2020-2026)
1.2.2 Purity ≥ 97%
1.2.3 Purity ≥ 98%
1.2.4 Purity ≥ 99%
1.3 Mesalamine Segment by Application
1.3.1 Global Mesalamine Sales Comparison by Application (2020-2026)
1.3.2 Mesalazine Tablets
1.3.3 Mesalazine Capsules
1.3.4 Others
1.4 Mesalamine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Mesalamine Sales Growth Rate (2015-2026)
1.4.2 Global Mesalamine Revenue and Growth Rate (2015-2026)
1.4.3 Global Mesalamine Price Trends (2015-2026)

2 Mesalamine Estimate and Forecast by Region
2.1 Global Mesalamine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Mesalamine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Mesalamine Sales Market Share by Region (2015-2020)
2.2.2 Global Mesalamine Revenue Market Share by Region (2015-2020)
2.3 Global Mesalamine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Mesalamine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Mesalamine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Mesalamine Estimates and Projections (2015-2026)
2.4.2 Europe Mesalamine Estimates and Projections (2015-2026)
2.4.3 China Mesalamine Estimates and Projections (2015-2026)
2.4.4 Japan Mesalamine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Mesalamine Estimates and Projections (2015-2026)
2.4.6 India Mesalamine Estimates and Projections (2015-2026)
3 Global Mesalamine Competition Landscape by Players
3.1 Global Top Mesalamine Players by Sales (2015-2020)
3.2 Global Top Mesalamine Players by Revenue (2015-2020)
3.3 Global Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalamine as of 2019)
3.4 Global Mesalamine Average Price by Company (2015-2020)
3.5 Manufacturers Mesalamine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Mesalamine Players (Opinion Leaders)
4 Global Mesalamine Market Size by Type
4.1 Global Mesalamine Historic Market Review by Type (2015-2020)
4.1.1 Global Mesalamine Sales Market Share by Type (2015-2020)
4.1.2 Global Mesalamine Revenue Market Share by Type (2015-2020)
4.1.3 Global Mesalamine Price by Type (2015-2020)
4.2 Global Mesalamine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Mesalamine Sales Forecast by Type (2021-2026)
4.2.2 Global Mesalamine Revenue Forecast by Type (2021-2026)
4.2.3 Global Mesalamine Price Forecast by Type (2021-2026)
5 Global Mesalamine Market Size by Application
5.1 Global Mesalamine Historic Market Review by Application (2015-2020)
5.1.1 Global Mesalamine Sales Market Share by Application (2015-2020)
5.1.2 Global Mesalamine Revenue Market Share by Application (2015-2020)
5.1.3 Global Mesalamine Price by Application (2015-2020)
5.2 Global Mesalamine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Mesalamine Sales Forecast by Application (2021-2026)
5.2.2 Global Mesalamine Revenue Forecast by Application (2021-2026)
5.2.3 Global Mesalamine Price Forecast by Application (2021-2026)

6 United States Mesalamine Market Facts & Figures
6.1 United States Mesalamine Sales Market Share by Company (2015-2020)
6.2 United States Mesalamine Sales Market Share by Type (2015-2020)
6.3 United States Mesalamine Sales Market Share by Application (2015-2020)

7 Europe Mesalamine Market Facts & Figures
7.1 Europe Mesalamine Sales Market Share by Company (2015-2020)
7.2 Europe Mesalamine Sales Market Share by Type (2015-2020)
7.3 Europe Mesalamine Sales Market Share by Application (2015-2020)

8 China Mesalamine Market Facts & Figures
8.1 China Mesalamine Sales Market Share by Company (2015-2020)
8.2 China Mesalamine Sales Market Share by Type (2015-2020)
8.3 China Mesalamine Sales Market Share by Application (2015-2020)

9 Japan Mesalamine Market Facts & Figures
9.1 Japan Mesalamine Sales Market Share by Company (3015-3030)
9.2 Japan Mesalamine Sales Market Share by Type (2015-2020)
9.3 Japan Mesalamine Sales Market Share by Application (2015-2020)

10 Southeast Asia Mesalamine Market Facts & Figures
10.1 Southeast Asia Mesalamine Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Mesalamine Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Mesalamine Sales Market Share by Application (2015-2020)

11 India Mesalamine Market Facts & Figures
11.1 India Mesalamine Sales Market Share by Company (2015-2020)
11.2 India Mesalamine Sales Market Share by Type (2015-2020)
11.3 India Mesalamine Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Mesalamine Business
12.1 Syntese A/S
12.1.1 Syntese A/S Corporation Information
12.1.2 Syntese A/S Business Overview
12.1.3 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Syntese A/S Mesalamine Products Offered
12.1.5 Syntese A/S Recent Development
12.2 Divis Laboratories
12.2.1 Divis Laboratories Corporation Information
12.2.2 Divis Laboratories Business Overview
12.2.3 Divis Laboratories Mesalamine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Divis Laboratories Mesalamine Products Offered
12.2.5 Divis Laboratories Recent Development
12.3 Cambrex Corporation
12.3.1 Cambrex Corporation Corporation Information
12.3.2 Cambrex Corporation Business Overview
12.3.3 Cambrex Corporation Mesalamine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Cambrex Corporation Mesalamine Products Offered
12.3.5 Cambrex Corporation Recent Development
12.4 Ipca Laboratories
12.4.1 Ipca Laboratories Corporation Information
12.4.2 Ipca Laboratories Business Overview
12.4.3 Ipca Laboratories Mesalamine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Ipca Laboratories Mesalamine Products Offered
12.4.5 Ipca Laboratories Recent Development
12.5 Hangzhou Brother
12.5.1 Hangzhou Brother Corporation Information
12.5.2 Hangzhou Brother Business Overview
12.5.3 Hangzhou Brother Mesalamine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Hangzhou Brother Mesalamine Products Offered
12.5.5 Hangzhou Brother Recent Development
12.6 PharmaZell
12.6.1 PharmaZell Corporation Information
12.6.2 PharmaZell Business Overview
12.6.3 PharmaZell Mesalamine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 PharmaZell Mesalamine Products Offered
12.6.5 PharmaZell Recent Development
12.7 Lianyungang Fengheng Biopharm
12.7.1 Lianyungang Fengheng Biopharm Corporation Information
12.7.2 Lianyungang Fengheng Biopharm Business Overview
12.7.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Lianyungang Fengheng Biopharm Mesalamine Products Offered
12.7.5 Lianyungang Fengheng Biopharm Recent Development
12.8 Lasa Loboratory
12.8.1 Lasa Loboratory Corporation Information
12.8.2 Lasa Loboratory Business Overview
12.8.3 Lasa Loboratory Mesalamine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Lasa Loboratory Mesalamine Products Offered
12.8.5 Lasa Loboratory Recent Development
12.9 Erregierre SpA
12.9.1 Erregierre SpA Corporation Information
12.9.2 Erregierre SpA Business Overview
12.9.3 Erregierre SpA Mesalamine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Erregierre SpA Mesalamine Products Offered
12.9.5 Erregierre SpA Recent Development
12.10 Corden Pharma Bergamo
12.10.1 Corden Pharma Bergamo Corporation Information
12.10.2 Corden Pharma Bergamo Business Overview
12.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Corden Pharma Bergamo Mesalamine Products Offered
12.10.5 Corden Pharma Bergamo Recent Development
12.11 CTX Lifescience
12.11.1 CTX Lifescience Corporation Information
12.11.2 CTX Lifescience Business Overview
12.11.3 CTX Lifescience Mesalamine Sales, Revenue and Gross Margin (2015-2020)
12.11.4 CTX Lifescience Mesalamine Products Offered
12.11.5 CTX Lifescience Recent Development
12.12 Ishita Active Pharma Ingredients
12.12.1 Ishita Active Pharma Ingredients Corporation Information
12.12.2 Ishita Active Pharma Ingredients Business Overview
12.12.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Ishita Active Pharma Ingredients Mesalamine Products Offered
12.12.5 Ishita Active Pharma Ingredients Recent Development
12.13 YC Biotech (Jiangsu)
12.13.1 YC Biotech (Jiangsu) Corporation Information
12.13.2 YC Biotech (Jiangsu) Business Overview
12.13.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue and Gross Margin (2015-2020)
12.13.4 YC Biotech (Jiangsu) Mesalamine Products Offered
12.13.5 YC Biotech (Jiangsu) Recent Development
12.14 Xinxiang Tianfeng Fine Chemical
12.14.1 Xinxiang Tianfeng Fine Chemical Corporation Information
12.14.2 Xinxiang Tianfeng Fine Chemical Business Overview
12.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Products Offered
12.14.5 Xinxiang Tianfeng Fine Chemical Recent Development

13 Mesalamine Manufacturing Cost Analysis
13.1 Mesalamine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Mesalamine
13.4 Mesalamine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Mesalamine Distributors List
14.3 Mesalamine Customers

15 Market Dynamics
15.1 Mesalamine Market Trends
15.2 Mesalamine Opportunities and Drivers
15.3 Mesalamine Market Challenges
15.4 Mesalamine Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Mesalamine Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Mesalamine Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Mesalamine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Mesalamine Sales (MT) by Region (2015-2020)
Table 5. Global Mesalamine Sales Market Share by Region (2015-2020)
Table 6. Global Mesalamine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Mesalamine Revenue Share by Region (2015-2020)
Table 8. Global Mesalamine Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Mesalamine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Mesalamine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Mesalamine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Mesalamine (MT) of Key Companies (2015-2020)
Table 13. Global Mesalamine Sales Share by Company (2015-2020)
Table 14. Global Mesalamine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Mesalamine Revenue Share by Company (2015-2020)
Table 16. Global Mesalamine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalamine as of 2019)
Table 17. Global Mesalamine Average Price (USD/Kg) of Key Company (2015-2020)
Table 18. Manufacturers Mesalamine Manufacturing Sites and Area Served
Table 19. Manufacturers Mesalamine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Mesalamine Players
Table 22. Global Mesalamine Sales (MT) by Type (2015-2020)
Table 23. Global Mesalamine Sales Share by Type (2015-2020)
Table 24. Global Mesalamine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Mesalamine Price (MT) by Type (2015-2020)
Table 26. Global Mesalamine Sales Share by Type (2021-2026)
Table 27. Global Mesalamine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Mesalamine Revenue Share by Type (2021-2026)
Table 29. Global Mesalamine Price (MT) by Type (2021-2026)
Table 30. Global Mesalamine Sales (MT) by Application (2015-2020)
Table 31. Global Mesalamine Sales Share by Application (2015-2020)
Table 32. Global Mesalamine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Mesalamine Price (MT) by Application (2015-2020)
Table 34. Global Mesalamine Sales (MT) by Application (2021-2026)
Table 35. Global Mesalamine Sales Share by Application (2021-2026)
Table 36. Global Mesalamine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Mesalamine Revenue Share by Application (2021-2026)
Table 38. Global Mesalamine Price (MT) by Application (2021-2026)
Table 39. United States Mesalamine Sales (MT) by Company (2015-2020)
Table 40. United States Mesalamine Sales Market Share by Company (2015-2020)
Table 41. United States Mesalamine Sales (MT) by Type (2015-2020)
Table 42. United States Mesalamine Sales Market Share by Type (2015-2020)
Table 43. United States Mesalamine Sales (MT) by Application (2015-2020)
Table 44. United States Mesalamine Sales Market Share by Application (2015-2020)
Table 45. Europe Mesalamine Sales (MT) by Company (2015-2020)
Table 46. Europe Mesalamine Sales Market Share by Company (2015-2020)
Table 47. Europe Mesalamine Sales (MT) by Type (2015-2020)
Table 48. Europe Mesalamine Sales Market Share by Type (2015-2020)
Table 49. Europe Mesalamine Sales (MT) by Application (2015-2020)
Table 50. Europe Mesalamine Sales Market Share by Type (2015-2020)
Table 51. China Mesalamine Sales (MT) by Company (2015-2020)
Table 52. China Mesalamine Sales Market Share by Company (2015-2020)
Table 53. China Mesalamine Sales (MT) by Type (2015-2020)
Table 54. China Mesalamine Sales Market Share by Type (2015-2020)
Table 55. China Mesalamine Sales (MT) by Application (2015-2020)
Table 56. China Mesalamine Sales Market Share by Application (2015-2020)
Table 57. Japan Mesalamine Sales (MT) by Company (2015-2020)
Table 58. Japan Mesalamine Sales Market Share by Company (2015-2020)
Table 59. Japan Mesalamine Sales (MT) by Type (2015-2020)
Table 60. Japan Mesalamine Sales Market Share by Type (2015-2020)
Table 61. Japan Mesalamine Sales (MT) by Application (2015-2020)
Table 62. Japan Mesalamine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Mesalamine Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Mesalamine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Mesalamine Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Mesalamine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Mesalamine Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Mesalamine Sales Market Share by Application (2015-2020)
Table 69. India Mesalamine Sales (MT) by Company (2015-2020)
Table 70. India Mesalamine Sales Market Share by Company (2015-2020)
Table 71. India Mesalamine Sales (MT) by Type (2015-2020)
Table 72. India Mesalamine Sales Market Share by Type (2015-2020)
Table 73. India Mesalamine Sales (MT) by Application (2015-2020)
Table 74. India Mesalamine Sales Market Share by Application (2015-2020)
Table 75. Syntese A/S Corporation Information
Table 76. Syntese A/S Description and Business Overview
Table 77. Syntese A/S Mesalamine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 78. Syntese A/S Mesalamine Product
Table 79. Syntese A/S Recent Development
Table 80. Divis Laboratories Corporation Information
Table 81. Divis Laboratories Description and Business Overview
Table 82. Divis Laboratories Mesalamine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Divis Laboratories Mesalamine Product
Table 84. Divis Laboratories Recent Development
Table 85. Cambrex Corporation Corporation Information
Table 86. Cambrex Corporation Description and Business Overview
Table 87. Cambrex Corporation Mesalamine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Cambrex Corporation Mesalamine Product
Table 89. Cambrex Corporation Recent Development
Table 90. Ipca Laboratories Corporation Information
Table 91. Ipca Laboratories Description and Business Overview
Table 92. Ipca Laboratories Mesalamine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Ipca Laboratories Mesalamine Product
Table 94. Ipca Laboratories Recent Development
Table 95. Hangzhou Brother Corporation Information
Table 96. Hangzhou Brother Description and Business Overview
Table 97. Hangzhou Brother Mesalamine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Hangzhou Brother Mesalamine Product
Table 99. Hangzhou Brother Recent Development
Table 100. PharmaZell Corporation Information
Table 101. PharmaZell Description and Business Overview
Table 102. PharmaZell Mesalamine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. PharmaZell Mesalamine Product
Table 104. PharmaZell Recent Development
Table 105. Lianyungang Fengheng Biopharm Corporation Information
Table 106. Lianyungang Fengheng Biopharm Description and Business Overview
Table 107. Lianyungang Fengheng Biopharm Mesalamine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Lianyungang Fengheng Biopharm Mesalamine Product
Table 109. Lianyungang Fengheng Biopharm Recent Development
Table 110. Lasa Loboratory Corporation Information
Table 111. Lasa Loboratory Mesalamine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Lasa Loboratory Description and Business Overview
Table 113. Lasa Loboratory Mesalamine Product
Table 114. Lasa Loboratory Recent Development
Table 115. Erregierre SpA Corporation Information
Table 116. Erregierre SpA Mesalamine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Erregierre SpA Description and Business Overview
Table 118. Erregierre SpA Mesalamine Product
Table 119. Erregierre SpA Recent Development
Table 120. Corden Pharma Bergamo Corporation Information
Table 121. Corden Pharma Bergamo Description and Business Overview
Table 122. Corden Pharma Bergamo Mesalamine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 123. Corden Pharma Bergamo Mesalamine Product
Table 124. Corden Pharma Bergamo Recent Development
Table 125. CTX Lifescience Corporation Information
Table 126. CTX Lifescience Description and Business Overview
Table 127. CTX Lifescience Mesalamine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. CTX Lifescience Mesalamine Product
Table 129. CTX Lifescience Recent Development
Table 130. Ishita Active Pharma Ingredients Corporation Information
Table 131. Ishita Active Pharma Ingredients Description and Business Overview
Table 132. Ishita Active Pharma Ingredients Mesalamine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Ishita Active Pharma Ingredients Mesalamine Product
Table 134. Ishita Active Pharma Ingredients Recent Development
Table 135. YC Biotech (Jiangsu) Corporation Information
Table 136. YC Biotech (Jiangsu) Description and Business Overview
Table 137. YC Biotech (Jiangsu) Mesalamine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 138. YC Biotech (Jiangsu) Mesalamine Product
Table 139. YC Biotech (Jiangsu) Recent Development
Table 140. Xinxiang Tianfeng Fine Chemical Corporation Information
Table 141. Xinxiang Tianfeng Fine Chemical Description and Business Overview
Table 142. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 143. Xinxiang Tianfeng Fine Chemical Mesalamine Product
Table 144. Xinxiang Tianfeng Fine Chemical Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Mesalamine Distributors List
Table 148. Mesalamine Customers List
Table 149. Mesalamine Market Key Trends
Table 150. Mesalamine Key Opportunities and Drivers
Table 151. Mesalamine Market Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Mesalamine Product Picture
Figure 2. Global Mesalamine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Mesalamine Market Share by Application in 2020 & 2026
Figure 6. Mesalazine Tablets Examples
Figure 7. Mesalazine Capsules Examples
Figure 8. Others Examples
Figure 9. Global Mesalamine Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Mesalamine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Mesalamine Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Mesalamine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Mesalamine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Mesalamine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Mesalamine Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Mesalamine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Mesalamine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Mesalamine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Mesalamine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Mesalamine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Mesalamine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Mesalamine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Mesalamine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Mesalamine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Mesalamine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Mesalamine Players Market Share by Revenue in Mesalamine 2015 & 2019
Figure 27. Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Mesalamine Revenue Share by Type (2015-2020)
Figure 29. Global Mesalamine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Mesalamine Revenue Share by Application (2015-2020)
Figure 31. Global Mesalamine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Mesalamine Sales Market Share by Type in 2019
Figure 33. United States Mesalamine Sales Market Share by Type in 2019
Figure 34. Europe Mesalamine Sales Market Share by Company in 2019
Figure 35. Europe Mesalamine Sales Market Share by Type in 2019
Figure 36. Europe Mesalamine Sales Market Share by Application in 2019
Figure 37. China Mesalamine Sales Market Share by Company in 2019
Figure 38. China Mesalamine Sales Market Share by Type in 2019
Figure 39. China Mesalamine Sales Market Share by Application in 2019
Figure 40. Japan Mesalamine Sales Market Share by Company in 2019
Figure 41. Japan Mesalamine Sales Market Share by Type in 2019
Figure 42. Japan Mesalamine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Mesalamine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Mesalamine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Mesalamine Sales Market Share by Application in 2019
Figure 46. India Mesalamine Sales Market Share by Company in 2019
Figure 47. India Mesalamine Sales Market Share by Type in 2019
Figure 48. India Mesalamine Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Mesalamine
Figure 51. Manufacturing Process Analysis of Mesalamine
Figure 52. Mesalamine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed



• 英文レポート名:Global Mesalamine Sales Market Report 2020
• 日本語訳:メサラミンのグローバル販売市場 2020年
• レポートコード:MRC2102QY8825お問い合わせ(見積依頼・ご注文・質問)